Related Experiment Video
Updated: Dec 6, 2025

07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
683
Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in
Sarah Orfanos1,2, Ibrahim El Husseini1,2, Thomas Nahass1
1Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
ERJ Open Research
|October 12, 2020
Abstract:
#COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a.

